Progressis

The best and safest way to control to PRRSv in a breeding unit thanks to the Prime Boost Concept.

Available in :

  • 50 ml
CONTACT US FOR MORE INFORMATION

Product information

PRRSV (Porcine Reproductive and respiratory syndrome virus) is one of the most loss-causing agents in the global swine production. Partly due to reproductive losses plus birth of weak and viremic piglets from females viremic between day 70 of gestation and farrowing, partly due to the immunosuppressive action and respiratory disease in the infected naïve animal at any age. The virus is highly mutating and easily recombining between different strains into entirely new strains of potential high virulence. To control PRRSV on endemic farms internal biosecurity is key, which very often is an unfulfilled challenge. Finally, the single optimal PRRSV vaccine is not yet developed; MLV (modified live virus) PRRS vaccines have strong protection for “own” strain but poor cross-protection. INV (inactivated virus) PRRS vaccines have poor protection, when applied in naïve animals. However, Progressis produces a clinical and colostral protection when applied on previously naturally infected or MLV vaccinated animals. The optimal and safest PRRSV vaccination schedule is the Progressis Prime-Boost Concept, keeping breeding stock and new born PRRSV negative, with the potential of producing PRRSV negative piglets out of nurseries (app. 10 woa) depending on quality of biosecurity.

Why choose Progressis?

Safety (no live virus on farm)

Efficacy (better stabilization of the farm after a PRRSv outbreak)

Stable reproductive performances

The Science behind

Measuring How Recombination Re-shapes the Evolutionary History of PRRSV-2: A Genome-Based Phylodynamic Analysis of the Emergence of a Novel PRRSV-2 Variant

Nakarin Pamornchainavakul, Mariana Kikuti, Igor A. D. Paploski, Dennis N. Makau, Albert Rovira, Cesar A. Corzo and Kimberly VanderWaal

Measuring-How-Recomb (1.23 MB)Download

The use of a whole inactivated PRRS virus vaccine administered in sows and impact on maternally derived immunity and timing of PRRS virus infection in piglets

Gerard Eduard Martín-Valls, Preben Mortensen, Hepzibar Clilvert, Yanli Li, Martí Cortey, Melanie Sno, Timea Barna, Marisa Terré, Nicolas Guerra, Enric Mateu

The-use-of-a-whole-i (549.21 KB)Download

Porcine reproductive and respiratory syndrome virus genetic variability a management and diagnostic dilemma

Jessica Risser, Matthew Ackerman, Robert Evelsizer, Stephen Wu, Byungjoon Kwon and James Mark Hammer

Porcine-reproductive (1.43 MB)Download

Comparison of different vaccination schedules for sustaining the immune response against porcine reproductive and respiratory syndrome virus

I. Díaz, M. Gimeno, A. Callén, J. Pujols, S. López, C. Charreyre, F. Joisel, E. Mateu

Comparison-of-differ (1.04 MB)Download

From one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.